At present, the incidence of benign prostatic hyperplasia (Benign Prostatic Hyperplasia, BPH) in China is increasing, the incidence of people over 60 years old is up to 50%, which has become an important factor that threatens the health of middle-aged and elderly men. The main clinical manifestations of BPH are lower urinary tract symptoms (Lower Urinary Tract Symptoms, LUTS), including obstruction symptoms of unobstructed urination, slow flow of urine, bifurcations and drops. The symptoms of bladder irritation mainly with the increase of nocturia, frequency of urine, urgency of urine, incontinence and urinary incontinence seriously affect the quality of life of the patients, which should be paid attention to. Important diseases. In view of this, many foreign experts recommend LUTS to replace the prostatic hyperplasia, more suitable for the current development trend in the Department of Urology, from the perspective of precision medicine is more conducive to the diagnosis and treatment of patients.
In order to better understand the new ideas and new knowledge about prostate disease and LUTS diagnosis and treatment, improve the opportunity to communicate with the international top experts in the Department of Urology, the first hospital of Nanjing City, to understand the most advanced academic progress and better for the benefit of the patients. On 9 August, we invited the expert of the Department of Urology urine control field and LUTS. Professor Paul Abrams, who is an author, conducted academic exchanges to explore new ideas of BPH therapy and create new thinking.